> top > docs > PubMed:26615423 > annotations

PubMed:26615423 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T1 0-131 Sentence denotes Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
T2 132-234 Sentence denotes Centrosomal protein 55 (CEP55) is a cell cycle regulator implicated in development of certain cancers.
T3 235-377 Sentence denotes However, characteristics of CEP55 expression and its clinical/prognostic significance are unclear in human epithelial ovarian carcinoma (EOC).
T4 378-560 Sentence denotes Therefore, we investigated the expression and clinicopathological significance of CEP55 in patients with EOC and its role in regulating invasion and metastasis of ovarian cell lines.
T5 561-706 Sentence denotes CEP55 mRNA and protein expression levels were detected by quantitative real-time PCR (qRT-PCR), Western blotting, and immunohistochemistry (IHC).
T6 707-818 Sentence denotes Potential associations of CEP55 expression scores with clinical parameters and patient survival were evaluated.
T7 819-980 Sentence denotes CEP55 function was investigated further using RNA interference, wound healing assay, transwell assay, immunofluorescence analysis, qRT-PCR, and Western blotting.
T8 981-1127 Sentence denotes CEP55 was significantly upregulated in ovarian cancer cell lines and lesions compared with normal cells and adjacent noncancerous ovarian tissues.
T9 1128-1477 Sentence denotes In the 213 EOC samples, CEP55 protein levels were positively correlated with clinical stage (P < 0.001), lymph node metastasis (P < 0.001), intraperitoneal metastasis (P < 0.001), tumor recurrence (P < 0.001), differentiation grade (P < 0.001), residual tumor size (P < 0.001), ascites see tumor cells (P = 0.020), and serum CA153 level (P < 0.001).
T10 1478-1640 Sentence denotes Moreover, patients with aberrant CEP55 protein expression showed tendencies to receive neoadjuvant chemotherapy (P < 0.001) and cytoreductive surgery (P = 0.020).
T11 1641-1814 Sentence denotes By contrast, no significant correlation was detected between the protein levels and patient age, histological type, or serum CA125, CA199, CA724, NSE, CEA, and β-HCG levels.
T12 1815-1960 Sentence denotes Patients with high CEP55 protein expression had shorter overall survival and disease-free survival compared with those with low CEP55 expression.
T13 1961-2056 Sentence denotes Multivariate analysis implicated CEP55 as an independent prognostic indicator for EOC patients.
T14 2057-2171 Sentence denotes Additionally, downregulation of CEP55 in ovarian cancer cells remarkably inhibited cellular motility and invasion.
T15 2172-2330 Sentence denotes Aberrant CEP55 expression may predict unfavorable clinical outcomes in EOC patients and play an important role in regulating invasion in ovarian cancer cells.
T16 2331-2407 Sentence denotes Thus, CEP55 may serve as a prognostic marker and therapeutic target for EOC.

LitCoin-entities-OrganismTaxon-PD

Id Subject Object Predicate Lexical cue db_id
T1 336-341 OrganismTaxon denotes human NCBItxid:9606
T2 2029-2038 OrganismTaxon denotes indicator NCBItxid:189528

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
10919 16-38 GeneOrGeneProduct denotes centrosomal protein 55 NCBIGene:55165
10920 84-89 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
10921 102-130 DiseaseOrPhenotypicFeature denotes epithelial ovarian carcinoma MESH:D000077216
10922 132-154 GeneOrGeneProduct denotes Centrosomal protein 55 NCBIGene:55165
10923 156-161 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10924 226-233 DiseaseOrPhenotypicFeature denotes cancers MESH:D009369
10925 263-268 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10926 336-341 OrganismTaxon denotes human NCBITaxon:9606
10927 342-370 DiseaseOrPhenotypicFeature denotes epithelial ovarian carcinoma MESH:D000077216
10928 372-375 DiseaseOrPhenotypicFeature denotes EOC MESH:D000077216
10929 460-465 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10930 469-477 OrganismTaxon denotes patients NCBITaxon:9606
10931 483-486 DiseaseOrPhenotypicFeature denotes EOC MESH:D000077216
10932 527-548 DiseaseOrPhenotypicFeature denotes metastasis of ovarian MESH:D010051
10933 561-566 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10934 733-738 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10935 786-793 OrganismTaxon denotes patient NCBITaxon:9606
10936 819-824 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10937 981-986 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10938 1020-1034 DiseaseOrPhenotypicFeature denotes ovarian cancer MESH:D010051
10939 1139-1142 DiseaseOrPhenotypicFeature denotes EOC MESH:D000077216
10940 1152-1157 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10941 1233-1254 DiseaseOrPhenotypicFeature denotes lymph node metastasis MESH:D008207
10942 1268-1294 DiseaseOrPhenotypicFeature denotes intraperitoneal metastasis MESH:D009362
10943 1308-1313 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
10944 1382-1387 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
10945 1406-1413 DiseaseOrPhenotypicFeature denotes ascites MESH:D001201
10946 1418-1423 DiseaseOrPhenotypicFeature denotes tumor MESH:D009369
10947 1453-1458 GeneOrGeneProduct denotes CA153 NCBIGene:4582
10948 1488-1496 OrganismTaxon denotes patients NCBITaxon:9606
10949 1511-1516 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10950 1725-1732 OrganismTaxon denotes patient NCBITaxon:9606
10951 1766-1771 GeneOrGeneProduct denotes CA125 NCBIGene:94025
10952 1773-1778 GeneOrGeneProduct denotes CA199 NCBIGene:94025
10953 1780-1785 GeneOrGeneProduct denotes CA724 NCBIGene:94025
10954 1787-1790 GeneOrGeneProduct denotes NSE NCBIGene:2026
10955 1792-1795 GeneOrGeneProduct denotes CEA NCBIGene:1084
10956 1801-1806 GeneOrGeneProduct denotes β-HCG NCBIGene:93659
10957 1815-1823 OrganismTaxon denotes Patients NCBITaxon:9606
10958 1834-1839 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10959 1943-1948 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10960 1994-1999 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10961 2043-2046 DiseaseOrPhenotypicFeature denotes EOC MESH:D000077216
10962 2047-2055 OrganismTaxon denotes patients NCBITaxon:9606
10963 2089-2094 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10964 2098-2112 DiseaseOrPhenotypicFeature denotes ovarian cancer MESH:D010051
10965 2181-2186 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10966 2243-2246 DiseaseOrPhenotypicFeature denotes EOC MESH:D000077216
10967 2247-2255 OrganismTaxon denotes patients NCBITaxon:9606
10968 2309-2323 DiseaseOrPhenotypicFeature denotes ovarian cancer MESH:D010051
10969 2337-2342 GeneOrGeneProduct denotes CEP55 NCBIGene:55165
10970 2403-2406 DiseaseOrPhenotypicFeature denotes EOC MESH:D000077216

LitCoin_Mondo

Id Subject Object Predicate Lexical cue mondo_id
T1 113-130 DiseaseOrPhenotypicFeature denotes ovarian carcinoma 0005140
T2 121-130 DiseaseOrPhenotypicFeature denotes carcinoma 0004993
T3 226-233 DiseaseOrPhenotypicFeature denotes cancers 0004992
T4 353-370 DiseaseOrPhenotypicFeature denotes ovarian carcinoma 0005140
T5 361-370 DiseaseOrPhenotypicFeature denotes carcinoma 0004993
T6 1020-1034 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170
T7 1028-1034 DiseaseOrPhenotypicFeature denotes cancer 0004992
T8 2098-2112 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170
T9 2106-2112 DiseaseOrPhenotypicFeature denotes cancer 0004992
T10 2309-2323 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170
T11 2317-2323 DiseaseOrPhenotypicFeature denotes cancer 0004992

LitCoin-GeneOrGeneProduct-v2

Id Subject Object Predicate Lexical cue
T1 16-38 GeneOrGeneProduct denotes centrosomal protein 55
T2 132-151 GeneOrGeneProduct denotes Centrosomal protein
T3 156-161 GeneOrGeneProduct denotes CEP55
T4 168-188 GeneOrGeneProduct denotes cell cycle regulator
T5 263-268 GeneOrGeneProduct denotes CEP55
T6 325-332 GeneOrGeneProduct denotes unclear
T7 460-465 GeneOrGeneProduct denotes CEP55
T8 549-553 GeneOrGeneProduct denotes cell
T9 554-559 GeneOrGeneProduct denotes lines
T10 561-566 GeneOrGeneProduct denotes CEP55
T11 567-571 GeneOrGeneProduct denotes mRNA
T12 576-583 GeneOrGeneProduct denotes protein
T13 632-641 GeneOrGeneProduct denotes real-time
T14 733-738 GeneOrGeneProduct denotes CEP55
T15 819-824 GeneOrGeneProduct denotes CEP55
T16 981-986 GeneOrGeneProduct denotes CEP55
T17 1035-1039 GeneOrGeneProduct denotes cell
T18 1040-1045 GeneOrGeneProduct denotes lines
T19 1050-1057 GeneOrGeneProduct denotes lesions
T20 1152-1157 GeneOrGeneProduct denotes CEP55
T21 1158-1165 GeneOrGeneProduct denotes protein
T22 1511-1516 GeneOrGeneProduct denotes CEP55
T23 1517-1524 GeneOrGeneProduct denotes protein
T24 1706-1713 GeneOrGeneProduct denotes protein
T25 1766-1771 GeneOrGeneProduct denotes CA125
T26 1829-1833 GeneOrGeneProduct denotes high
T27 1834-1839 GeneOrGeneProduct denotes CEP55
T28 1840-1847 GeneOrGeneProduct denotes protein
T29 1943-1948 GeneOrGeneProduct denotes CEP55
T30 1994-1999 GeneOrGeneProduct denotes CEP55
T31 2089-2094 GeneOrGeneProduct denotes CEP55
T32 2181-2186 GeneOrGeneProduct denotes CEP55
T33 2337-2342 GeneOrGeneProduct denotes CEP55

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T1 16-38 GeneOrGeneProduct denotes centrosomal protein 55
T2 84-89 GeneOrGeneProduct denotes tumor
T3 132-151 GeneOrGeneProduct denotes Centrosomal protein
T4 156-161 GeneOrGeneProduct denotes CEP55
T5 168-188 GeneOrGeneProduct denotes cell cycle regulator
T6 263-268 GeneOrGeneProduct denotes CEP55
T7 325-332 GeneOrGeneProduct denotes unclear
T8 460-465 GeneOrGeneProduct denotes CEP55
T9 503-513 GeneOrGeneProduct denotes regulating
T10 549-553 GeneOrGeneProduct denotes cell
T11 554-559 GeneOrGeneProduct denotes lines
T12 561-566 GeneOrGeneProduct denotes CEP55
T13 567-571 GeneOrGeneProduct denotes mRNA
T14 576-583 GeneOrGeneProduct denotes protein
T15 632-641 GeneOrGeneProduct denotes real-time
T16 665-673 GeneOrGeneProduct denotes blotting
T17 733-738 GeneOrGeneProduct denotes CEP55
T18 819-824 GeneOrGeneProduct denotes CEP55
T19 971-979 GeneOrGeneProduct denotes blotting
T20 981-986 GeneOrGeneProduct denotes CEP55
T21 1035-1039 GeneOrGeneProduct denotes cell
T22 1040-1045 GeneOrGeneProduct denotes lines
T23 1050-1057 GeneOrGeneProduct denotes lesions
T24 1079-1084 GeneOrGeneProduct denotes cells
T25 1152-1157 GeneOrGeneProduct denotes CEP55
T26 1158-1165 GeneOrGeneProduct denotes protein
T27 1233-1238 GeneOrGeneProduct denotes lymph
T28 1239-1243 GeneOrGeneProduct denotes node
T29 1308-1313 GeneOrGeneProduct denotes tumor
T30 1382-1387 GeneOrGeneProduct denotes tumor
T31 1388-1392 GeneOrGeneProduct denotes size
T32 1418-1423 GeneOrGeneProduct denotes tumor
T33 1424-1429 GeneOrGeneProduct denotes cells
T34 1453-1458 GeneOrGeneProduct denotes CA153
T35 1511-1516 GeneOrGeneProduct denotes CEP55
T36 1517-1524 GeneOrGeneProduct denotes protein
T37 1644-1652 GeneOrGeneProduct denotes contrast
T38 1706-1713 GeneOrGeneProduct denotes protein
T39 1766-1771 GeneOrGeneProduct denotes CA125
T40 1829-1833 GeneOrGeneProduct denotes high
T41 1834-1839 GeneOrGeneProduct denotes CEP55
T42 1840-1847 GeneOrGeneProduct denotes protein
T43 1943-1948 GeneOrGeneProduct denotes CEP55
T44 1994-1999 GeneOrGeneProduct denotes CEP55
T45 2089-2094 GeneOrGeneProduct denotes CEP55
T46 2113-2118 GeneOrGeneProduct denotes cells
T47 2181-2186 GeneOrGeneProduct denotes CEP55
T48 2202-2209 GeneOrGeneProduct denotes predict
T49 2286-2296 GeneOrGeneProduct denotes regulating
T50 2324-2329 GeneOrGeneProduct denotes cells
T51 2337-2342 GeneOrGeneProduct denotes CEP55
T52 2347-2352 GeneOrGeneProduct denotes serve

LitCoin-Disease-MeSH

Id Subject Object Predicate Lexical cue originalLabel
T1 84-89 DiseaseOrPhenotypicFeature denotes tumor D009369
T2 102-130 DiseaseOrPhenotypicFeature denotes epithelial ovarian carcinoma D000077216
T3 226-233 DiseaseOrPhenotypicFeature denotes cancers D009369
T4 342-370 DiseaseOrPhenotypicFeature denotes epithelial ovarian carcinoma D000077216
T5 372-375 DiseaseOrPhenotypicFeature denotes EOC D000077216
T6 483-486 DiseaseOrPhenotypicFeature denotes EOC D000077216
T7 527-537 DiseaseOrPhenotypicFeature denotes metastasis D009362
T8 883-888 DiseaseOrPhenotypicFeature denotes wound D014947
T9 1020-1034 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T10 1139-1142 DiseaseOrPhenotypicFeature denotes EOC D000077216
T11 1233-1254 DiseaseOrPhenotypicFeature denotes lymph node metastasis D008207
T12 1284-1294 DiseaseOrPhenotypicFeature denotes metastasis D009362
T13 1308-1313 DiseaseOrPhenotypicFeature denotes tumor D009369
T14 1314-1324 DiseaseOrPhenotypicFeature denotes recurrence D012008
T15 1373-1387 DiseaseOrPhenotypicFeature denotes residual tumor D018365
T16 1406-1413 DiseaseOrPhenotypicFeature denotes ascites D001201
T17 1418-1423 DiseaseOrPhenotypicFeature denotes tumor D009369
T18 1892-1899 DiseaseOrPhenotypicFeature denotes disease D004194
T19 2043-2046 DiseaseOrPhenotypicFeature denotes EOC D000077216
T20 2098-2112 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T21 2243-2246 DiseaseOrPhenotypicFeature denotes EOC D000077216
T22 2309-2323 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T23 2403-2406 DiseaseOrPhenotypicFeature denotes EOC D000077216

LitCoin-GeneOrGeneProduct-v3

Id Subject Object Predicate Lexical cue
T1 16-38 GeneOrGeneProduct denotes centrosomal protein 55
T2 132-151 GeneOrGeneProduct denotes Centrosomal protein
T3 156-161 GeneOrGeneProduct denotes CEP55
T4 168-188 GeneOrGeneProduct denotes cell cycle regulator
T5 263-268 GeneOrGeneProduct denotes CEP55
T6 460-465 GeneOrGeneProduct denotes CEP55
T7 561-566 GeneOrGeneProduct denotes CEP55
T8 576-594 GeneOrGeneProduct denotes protein expression
T9 733-738 GeneOrGeneProduct denotes CEP55
T10 819-824 GeneOrGeneProduct denotes CEP55
T11 981-986 GeneOrGeneProduct denotes CEP55
T12 1152-1157 GeneOrGeneProduct denotes CEP55
T13 1511-1516 GeneOrGeneProduct denotes CEP55
T14 1517-1535 GeneOrGeneProduct denotes protein expression
T15 1766-1771 GeneOrGeneProduct denotes CA125
T16 1834-1839 GeneOrGeneProduct denotes CEP55
T17 1840-1858 GeneOrGeneProduct denotes protein expression
T18 1943-1948 GeneOrGeneProduct denotes CEP55
T19 1994-1999 GeneOrGeneProduct denotes CEP55
T20 2089-2094 GeneOrGeneProduct denotes CEP55
T21 2181-2186 GeneOrGeneProduct denotes CEP55
T22 2337-2342 GeneOrGeneProduct denotes CEP55

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T1 84-89 DiseaseOrPhenotypicFeature denotes tumor 0005070
T2 113-130 DiseaseOrPhenotypicFeature denotes ovarian carcinoma 0005140
T3 353-370 DiseaseOrPhenotypicFeature denotes ovarian carcinoma 0005140
T4 883-888 DiseaseOrPhenotypicFeature denotes wound 0021178
T5 1020-1034 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170|0005140
T7 1308-1313 DiseaseOrPhenotypicFeature denotes tumor 0005070
T8 1382-1387 DiseaseOrPhenotypicFeature denotes tumor 0005070
T9 1418-1423 DiseaseOrPhenotypicFeature denotes tumor 0005070
T10 2098-2112 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170|0005140
T12 2309-2323 DiseaseOrPhenotypicFeature denotes ovarian cancer 0008170|0005140

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T1 84-89 DiseaseOrPhenotypicFeature denotes tumor D009369
T2 102-130 DiseaseOrPhenotypicFeature denotes epithelial ovarian carcinoma D000077216
T3 226-233 DiseaseOrPhenotypicFeature denotes cancers D009369
T4 342-370 DiseaseOrPhenotypicFeature denotes epithelial ovarian carcinoma D000077216
T5 372-375 DiseaseOrPhenotypicFeature denotes EOC D000077216
T6 483-486 DiseaseOrPhenotypicFeature denotes EOC D000077216
T7 527-537 DiseaseOrPhenotypicFeature denotes metastasis D009362
T8 883-888 DiseaseOrPhenotypicFeature denotes wound D014947
T9 1020-1034 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T10 1139-1142 DiseaseOrPhenotypicFeature denotes EOC D000077216
T11 1233-1254 DiseaseOrPhenotypicFeature denotes lymph node metastasis D008207
T12 1284-1294 DiseaseOrPhenotypicFeature denotes metastasis D009362
T13 1308-1313 DiseaseOrPhenotypicFeature denotes tumor D009369
T14 1314-1324 DiseaseOrPhenotypicFeature denotes recurrence D012008
T15 1373-1387 DiseaseOrPhenotypicFeature denotes residual tumor D018365
T16 1406-1413 DiseaseOrPhenotypicFeature denotes ascites D001201
T17 1418-1423 DiseaseOrPhenotypicFeature denotes tumor D009369
T18 1892-1899 DiseaseOrPhenotypicFeature denotes disease D004194
T19 2043-2046 DiseaseOrPhenotypicFeature denotes EOC D000077216
T20 2098-2112 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T21 2243-2246 DiseaseOrPhenotypicFeature denotes EOC D000077216
T22 2309-2323 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T23 2403-2406 DiseaseOrPhenotypicFeature denotes EOC D000077216

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T1 84-89 DiseaseOrPhenotypicFeature denotes tumor D009369
T2 102-130 DiseaseOrPhenotypicFeature denotes epithelial ovarian carcinoma D000077216
T3 226-233 DiseaseOrPhenotypicFeature denotes cancers D009369
T4 342-370 DiseaseOrPhenotypicFeature denotes epithelial ovarian carcinoma D000077216
T5 372-375 DiseaseOrPhenotypicFeature denotes EOC D000077216
T6 483-486 DiseaseOrPhenotypicFeature denotes EOC D000077216
T7 1020-1034 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T8 1139-1142 DiseaseOrPhenotypicFeature denotes EOC D000077216
T9 1233-1254 DiseaseOrPhenotypicFeature denotes lymph node metastasis D008207
T10 1308-1313 DiseaseOrPhenotypicFeature denotes tumor D009369
T11 1373-1387 DiseaseOrPhenotypicFeature denotes residual tumor D018365
T12 1406-1413 DiseaseOrPhenotypicFeature denotes ascites D001201
T13 1418-1423 DiseaseOrPhenotypicFeature denotes tumor D009369
T14 2043-2046 DiseaseOrPhenotypicFeature denotes EOC D000077216
T15 2098-2112 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T16 2243-2246 DiseaseOrPhenotypicFeature denotes EOC D000077216
T17 2309-2323 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T18 2403-2406 DiseaseOrPhenotypicFeature denotes EOC D000077216

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T1 336-341 OrganismTaxon denotes human
T2 469-477 OrganismTaxon denotes patients
T3 786-793 OrganismTaxon denotes patient
T4 1488-1496 OrganismTaxon denotes patients
T5 1725-1732 OrganismTaxon denotes patient
T6 1792-1795 OrganismTaxon denotes CEA
T7 2047-2055 OrganismTaxon denotes patients
T8 2247-2255 OrganismTaxon denotes patients

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label
T22 2337-2342 GeneOrGeneProduct denotes CEP55
T21 2181-2186 GeneOrGeneProduct denotes CEP55
T20 2089-2094 GeneOrGeneProduct denotes CEP55
T19 1994-1999 GeneOrGeneProduct denotes CEP55
T18 1943-1948 GeneOrGeneProduct denotes CEP55
T17 1840-1858 GeneOrGeneProduct denotes protein expression
T16 1834-1839 GeneOrGeneProduct denotes CEP55
T15 1766-1771 GeneOrGeneProduct denotes CA125
T14 1517-1535 GeneOrGeneProduct denotes protein expression
T13 1511-1516 GeneOrGeneProduct denotes CEP55
T12 1152-1157 GeneOrGeneProduct denotes CEP55
T11 981-986 GeneOrGeneProduct denotes CEP55
T10 819-824 GeneOrGeneProduct denotes CEP55
T9 733-738 GeneOrGeneProduct denotes CEP55
T8 576-594 GeneOrGeneProduct denotes protein expression
T7 561-566 GeneOrGeneProduct denotes CEP55
T6 460-465 GeneOrGeneProduct denotes CEP55
T5 263-268 GeneOrGeneProduct denotes CEP55
T4 168-188 GeneOrGeneProduct denotes cell cycle regulator
T3 156-161 GeneOrGeneProduct denotes CEP55
T2 132-151 GeneOrGeneProduct denotes Centrosomal protein
T1 16-38 GeneOrGeneProduct denotes centrosomal protein 55
T12613 2403-2406 DiseaseOrPhenotypicFeature denotes EOC D000077216
T61386 2309-2323 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T84544 2243-2246 DiseaseOrPhenotypicFeature denotes EOC D000077216
T95299 2098-2112 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T57450 2043-2046 DiseaseOrPhenotypicFeature denotes EOC D000077216
T3276 1418-1423 DiseaseOrPhenotypicFeature denotes tumor D009369
T66686 1406-1413 DiseaseOrPhenotypicFeature denotes ascites D001201
T27874 1373-1387 DiseaseOrPhenotypicFeature denotes residual tumor D018365
T24130 1308-1313 DiseaseOrPhenotypicFeature denotes tumor D009369
T62122 1233-1254 DiseaseOrPhenotypicFeature denotes lymph node metastasis D008207
T52084 1139-1142 DiseaseOrPhenotypicFeature denotes EOC D000077216
T66297 1020-1034 DiseaseOrPhenotypicFeature denotes ovarian cancer D010051
T61716 483-486 DiseaseOrPhenotypicFeature denotes EOC D000077216
T35165 372-375 DiseaseOrPhenotypicFeature denotes EOC D000077216
T62581 342-370 DiseaseOrPhenotypicFeature denotes epithelial ovarian carcinoma D000077216
T60899 226-233 DiseaseOrPhenotypicFeature denotes cancers D009369
T72038 102-130 DiseaseOrPhenotypicFeature denotes epithelial ovarian carcinoma D000077216
T54451 84-89 DiseaseOrPhenotypicFeature denotes tumor D009369
T66364 2247-2255 OrganismTaxon denotes patients
T81125 2047-2055 OrganismTaxon denotes patients
T4385 1792-1795 OrganismTaxon denotes CEA
T62457 1725-1732 OrganismTaxon denotes patient
T89110 1488-1496 OrganismTaxon denotes patients
T74924 786-793 OrganismTaxon denotes patient
T46099 469-477 OrganismTaxon denotes patients
T11724 336-341 OrganismTaxon denotes human

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
26615423-0#16#38#gene55165 16-38 gene55165 denotes centrosomal protein 55
26615423-0#102#130#diseaseC0677886 102-130 diseaseC0677886 denotes epithelial ovarian carcinoma
26615423-14#9#14#gene55165 2181-2186 gene55165 denotes CEP55
26615423-14#137#151#diseaseC0029925 2309-2323 diseaseC0029925 denotes ovarian cancer
26615423-14#137#151#diseaseC1140680 2309-2323 diseaseC1140680 denotes ovarian cancer
26615423-8#24#29#gene55165 1152-1157 gene55165 denotes CEP55
26615423-8#156#166#diseaseC0027627 1284-1294 diseaseC0027627 denotes metastasis
26615423-8#105#126#diseaseC0686619 1233-1254 diseaseC0686619 denotes lymph node metastasis
26615423-8#180#196#diseaseC0521158 1308-1324 diseaseC0521158 denotes tumor recurrence
16#38#gene55165102#130#diseaseC0677886 26615423-0#16#38#gene55165 26615423-0#102#130#diseaseC0677886 associated_with centrosomal protein 55,epithelial ovarian carcinoma
9#14#gene55165137#151#diseaseC0029925 26615423-14#9#14#gene55165 26615423-14#137#151#diseaseC0029925 associated_with CEP55,ovarian cancer
9#14#gene55165137#151#diseaseC1140680 26615423-14#9#14#gene55165 26615423-14#137#151#diseaseC1140680 associated_with CEP55,ovarian cancer
24#29#gene55165156#166#diseaseC0027627 26615423-8#24#29#gene55165 26615423-8#156#166#diseaseC0027627 associated_with CEP55,metastasis
24#29#gene55165105#126#diseaseC0686619 26615423-8#24#29#gene55165 26615423-8#105#126#diseaseC0686619 associated_with CEP55,lymph node metastasis
24#29#gene55165180#196#diseaseC0521158 26615423-8#24#29#gene55165 26615423-8#180#196#diseaseC0521158 associated_with CEP55,tumor recurrence